Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | MRE11 | P49959 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | CTNNB1 | P35222 | 2/20 | 0.33 |
| ▸ | WNT3A | P56704 | 2/20 | 0.33 |
| ▸ | MPL | P40238 | 2/20 | 0.33 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.33 |
| ▸ | CDK2 | P24941 | 1/20 | 0.33 |
| ▸ | RORB | Q92753 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8683579 | 0.80 | HSD17B10 (0.39) | MEN1NPC1RAB9AKMT2ATP53 | |
| SCHEMBL8332823 | 0.76 | HSD17B10 (0.39) | MEN1NPC1RAB9AKMT2ATP53 | |
| SCHEMBL6662351 | 0.72 | MAPT (0.41) | MEN1NPC1RAB9AKMT2ATP53 | |
| SCHEMBL6662355 | 0.72 | MAPT (0.41) | MEN1NPC1RAB9AKMT2ATP53 | |
| SCHEMBL6826754 | 0.70 | LMNA (0.50) | SMN1; SMN2LMNAGAACTNNB1WNT3A | |
| SCHEMBL29392950 | 0.69 | MAPT (0.34) | MEN1NPC1RAB9AKMT2ATP53 | |
| SCHEMBL29359396 | 0.69 | MEN1 (0.47) | MEN1NPC1RAB9AKMT2ATP53 | |
| SCHEMBL13558725 | 0.65 | RAPGEF3 (0.40) | LMNAGAA | |
| SCHEMBL24910228 | 0.64 | MPL (0.42) | MEN1KMT2AMAPTL3MBTL1GAA | |
| SCHEMBL6829927 | 0.61 | GAA (0.43) | MEN1KMT2AHTTSMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040059122-A1 | Cyanothioacetamide derivative and process for producing the same | NIPPON SODA CO., LTD. (JP) | 2004-03-25 | — | — | US | disclosed |
| EP-1367049-A1 | CYANOTHIOACETAMIDE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME | NIPPON SODA CO., LTD. (JP) | 2003-12-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040059122-A1 | Cyanothioacetamide derivative and process for producing the same | NAT1, ACAA2, ACAT2 | MEN1 2943/4885NPC1 1787/4885RAB9A 2949/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.